These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31741333)

  • 61. Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes.
    Lempp FA; Wiedtke E; Qu B; Roques P; Chemin I; Vondran FWR; Le Grand R; Grimm D; Urban S
    Hepatology; 2017 Sep; 66(3):703-716. PubMed ID: 28195359
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Alteration of Mature Nucleocapsid and Enhancement of Covalently Closed Circular DNA Formation by Hepatitis B Virus Core Mutants Defective in Complete-Virion Formation.
    Cui X; Luckenbaugh L; Bruss V; Hu J
    J Virol; 2015 Oct; 89(19):10064-72. PubMed ID: 26202253
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Virus-host interplay in hepatitis B virus infection and epigenetic treatment strategies.
    Hensel KO; Rendon JC; Navas MC; Rots MG; Postberg J
    FEBS J; 2017 Nov; 284(21):3550-3572. PubMed ID: 28457020
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sirtuin 2 Isoform 1 Enhances Hepatitis B Virus RNA Transcription and DNA Synthesis through the AKT/GSK-3β/β-Catenin Signaling Pathway.
    Piracha ZZ; Kwon H; Saeed U; Kim J; Jung J; Chwae YJ; Park S; Shin HJ; Kim K
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111572
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Role of peroxisome proliferator-activated receptor gamma coactivator 1alpha in AKT/PKB-mediated inhibition of hepatitis B virus biosynthesis.
    Ondracek CR; McLachlan A
    J Virol; 2011 Nov; 85(22):11891-900. PubMed ID: 21880746
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Molecular genetics of HBV infection.
    Locarnini S; Zoulim F
    Antivir Ther; 2010; 15 Suppl 3():3-14. PubMed ID: 21041899
    [TBL] [Abstract][Full Text] [Related]  

  • 67. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
    Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
    Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Regulatory elements of hepatitis B virus transcription.
    Moolla N; Kew M; Arbuthnot P
    J Viral Hepat; 2002 Sep; 9(5):323-31. PubMed ID: 12225325
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Alpha/beta interferon differentially modulates the clearance of cytoplasmic encapsidated replication intermediates and nuclear covalently closed circular hepatitis B virus (HBV) DNA from the livers of hepatocyte nuclear factor 1alpha-null HBV transgenic mice.
    Anderson AL; Banks KE; Pontoglio M; Yaniv M; McLachlan A
    J Virol; 2005 Sep; 79(17):11045-52. PubMed ID: 16103155
    [TBL] [Abstract][Full Text] [Related]  

  • 70. siRNA combinations mediate greater suppression of hepatitis B virus replication in mice.
    Li G; Fu L; Jiang J; Ping Y; Huang Y; Wang Y
    Cell Biochem Biophys; 2014 Jul; 69(3):641-7. PubMed ID: 24549857
    [TBL] [Abstract][Full Text] [Related]  

  • 71. IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome.
    Palumbo GA; Scisciani C; Pediconi N; Lupacchini L; Alfalate D; Guerrieri F; Calvo L; Salerno D; Di Cocco S; Levrero M; Belloni L
    PLoS One; 2015; 10(11):e0142599. PubMed ID: 26580974
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Limited effects of fasting on hepatitis B virus (HBV) biosynthesis in HBV transgenic mice.
    Li L; Oropeza CE; Kaestner KH; McLachlan A
    J Virol; 2009 Feb; 83(4):1682-8. PubMed ID: 19073739
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Multiple nuclear receptors may regulate hepatitis B virus biosynthesis during development.
    Reese V; Ondracek C; Rushing C; Li L; Oropeza CE; McLachlan A
    Int J Biochem Cell Biol; 2011 Feb; 43(2):230-7. PubMed ID: 19941970
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hepatitis B Virus Epsilon (ε) RNA Element: Dynamic Regulator of Viral Replication and Attractive Therapeutic Target.
    Olenginski LT; Attionu SK; Henninger EN; LeBlanc RM; Longhini AP; Dayie TK
    Viruses; 2023 Sep; 15(9):. PubMed ID: 37766319
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Novel Molecular Therapeutics Targeting Signaling Pathway to Control Hepatitis B Viral Infection.
    Yan Y; Qiu Y; Davgadorj C; Zheng C
    Front Cell Infect Microbiol; 2022; 12():847539. PubMed ID: 35252042
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Unveiling the roles of HBV polymerase for new antiviral strategies.
    Clark DN; Hu J
    Future Virol; 2015; 10(3):283-295. PubMed ID: 25893003
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Gene therapeutic approaches to inhibit hepatitis B virus replication.
    Gebbing M; Bergmann T; Schulz E; Ehrhardt A
    World J Hepatol; 2015 Feb; 7(2):150-64. PubMed ID: 25729471
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Peroxisome proliferator-activated receptors in HBV-related infection.
    Dubuquoy L; Louvet A; Hollebecque A; Mathurin P; Dharancy S
    PPAR Res; 2009; 2009():145124. PubMed ID: 19365584
    [TBL] [Abstract][Full Text] [Related]  

  • 79. HBV replication inhibitors.
    Pierra Rouviere C; Dousson CB; Tavis JE
    Antiviral Res; 2020 Jul; 179():104815. PubMed ID: 32380149
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunopathogenesis of HBV Infection.
    Wu J; Han M; Li J; Yang X; Yang D
    Adv Exp Med Biol; 2020; 1179():71-107. PubMed ID: 31741334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.